This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Phi Biomed Inc., Pohang University of Science and Technology Foundation. Active years: 2025.
Company Filing History:
1 out of 2 
1 out of 1,098 Years Active: 2025
Title: Innovations by Jong Hwan Mun in Corneal Cross-Linking Technology.
Introduction
Jong Hwan Mun is an innovative inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the area of vision correction and corneal treatment. His work focuses on developing advanced systems that enhance the effectiveness of corneal cross-linking procedures.
Latest Patents
Jong Hwan Mun holds a patent for a "System for corneal cross-linking and correcting vision by using LED contact lens and eye dye." This invention relates to a system designed for the corneal cross-linking of injured corneas, treating keratoconus, or correcting vision. The system comprises a hyaluronic acid-dye conjugate and a contact lens that includes an LED light source. The dye is activated by light from the LED, generating radicals that form covalent bonds between amino acid radicals of corneal collagen, thereby strengthening the collagen layer. The hyaluronic acid-dye conjugate improves the dye's penetration in the cornea, while the contact lens enhances this effect. Additionally, the lens structure deforms the cornea's shape, providing a vision correction effect.
Career Highlights
Throughout his career, Jong Hwan Mun has worked with notable institutions, including the Pohang University of Science and Technology Foundation and Phi Biomed Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of vision correction.
Collaborations
Jong Hwan Mun has collaborated with Sei Kwang Hahn, contributing to the advancement of technologies in ophthalmology. Their partnership has fostered the development of innovative solutions for vision-related issues.
Conclusion
Jong Hwan Mun's contributions to corneal cross-linking technology demonstrate his commitment to improving vision correction methods. His innovative patent showcases the potential for enhanced treatment options in ophthalmology.